| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/24/2008 | US7390638 A polynucleotide encoding a carboxy-truncated interferon gamma (IFNG) polypeptide mutant exhibiting IFNG receptor binding activity having the amino acid sequence, SEQ ID NO:12, or 1-10 residue modifications; antitumor, -carcinogenic agent; viricides; interstitial lung diseases; autoimmune diseases |
| 06/24/2008 | US7390634 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation |
| 06/24/2008 | US7390632 Soluble ErbB3 receptor isoforms |
| 06/24/2008 | US7390630 Method of identifying a compound that selectively inhibits cytokine-stimulated T cell induced production of TNF-alpha by monocytes |
| 06/24/2008 | US7390526 Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon |
| 06/24/2008 | US7390494 Vaccine comprises nucleic acid encodes an immunogenic protein that induces a protective response effective against infection by a piglet weight loss disease circovirus; structural and non-structural polypeptides, vectors, and cells transformed by the vectors; kits for diagnosing |
| 06/24/2008 | US7390486 PRO4381 antibodies |
| 06/24/2008 | US7390484 Self-contained adipose derived stem cell processing unit |
| 06/24/2008 | US7390483 Modified by introduction of nucleic acid molecule comprising a nucleic acid sequence encoding granulocyte macrophage-colony stimulating factor (GM-CSF) operably linked to a promoter; contains cancer antigen; immunotherapy |
| 06/19/2008 | WO2008074025A2 Novel genes and rna molecules that confer stress tolerance |
| 06/19/2008 | WO2008073979A2 Near-infrared electromagnetic modification of cellular steady- state membrane potentials |
| 06/19/2008 | WO2008073893A2 Methods for producing an adenovirus type 5 gene transfer vector |
| 06/19/2008 | WO2008073748A1 Expansion of hematopoietic stem cells |
| 06/19/2008 | WO2008073598A2 Methods for improving antibody production |
| 06/19/2008 | WO2008073578A2 Plant genes involved in nitrate uptake and metabolism |
| 06/19/2008 | WO2008073348A2 Microgravity bioreactor systems for production of bioactive compounds and biological macromolecules |
| 06/19/2008 | WO2008073331A2 Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue |
| 06/19/2008 | WO2008073316A2 Identification and isolation of acute myeloid leukemia stem cells |
| 06/19/2008 | WO2008073201A2 Compositions and methods for identifying agents that alter expression of survivin |
| 06/19/2008 | WO2008073184A2 Genetic incorporation of unnatural amino acids into proteins in mammalian cells |
| 06/19/2008 | WO2008072540A1 Tol1 FACTOR TRANSPOSASE AND DNA INTRODUCTION SYSTEM USING THE SAME |
| 06/19/2008 | WO2008071987A1 Prostate stem cell model |
| 06/19/2008 | WO2008071974A2 Use of pi3k m-tor and akt inhibitors to induce f0xp3 expression and generate regulatory t cells |
| 06/19/2008 | WO2008071806A1 Antibodies against human cytomegalovirus (hcmv) |
| 06/19/2008 | WO2008071701A1 Expression of transgenic t cell receptors in lak-t cells |
| 06/19/2008 | WO2008071074A1 The use of mesenchymal stem cells and the separating and preserving method of stem cells from human tissues |
| 06/19/2008 | WO2008071010A1 Combination treatments with selected growth/hormone regulatory factors for diabetes and related diseases |
| 06/19/2008 | WO2008070893A1 Promoting ecm production by fibroblast cells and/or promoting migration of fibroblast cells in a biological system |
| 06/19/2008 | WO2008070892A1 Promoting production of extracellular matrix by fibroblast cells and/or promoting migration of fibroblast cells |
| 06/19/2008 | WO2008055069A3 Poultry vaccine, for necrotic enteritis, comprising a mutated clostridium perfringens alpha toxin antigen, and methods of producing the vaccine |
| 06/19/2008 | WO2008042174A3 Mesenchymal stem cells and uses therefor |
| 06/19/2008 | WO2007137300A3 Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods |
| 06/19/2008 | WO2007095321A3 Mitotic progression genes and methods of modulating mitosis |
| 06/19/2008 | WO2007076115A3 Nitrogen-efficient monocot plants |
| 06/19/2008 | WO2007045691A8 Renal carcinoma cell line and use thereof |
| 06/19/2008 | WO2005079250A3 Purines are self-renewal signals for neural stem cells, and purine receptor antagonists promote neuronal and glial differentiation therefrom |
| 06/19/2008 | WO2001034766A3 Protein monitoring the activity of small gtp-binding protein |
| 06/19/2008 | US20080148433 Expression vector comprising nucleotide sequences coding malonyl-CoA:ACP acyltransferase (MAT), beta -keto acyl-ACP synthase (KS) and ketoreductase (KR) for transforming and propagating cells with enhanced concentrations of polyunsaturated fatty acid (PUFA) |
| 06/19/2008 | US20080148432 Recombinant cell for use in propagation of freeze and drought resistant plants with enhanced oil and seed protein production |
| 06/19/2008 | US20080148430 Using transgenic plants as bioreactor for measuring or detecting mitogen-activated protein (MAP) kinase activity |
| 06/19/2008 | US20080148429 Mitochondrial DNA sequences for use as diagnostic indicator of plants manifesting cytoplasmic male sterile phenotypes |
| 06/19/2008 | US20080148428 Transgenic crop plant for propagating herbicide tolerant, insect, pest and/or disease resistant plants with enhanced fatty acid and carbohydrate metabolism |
| 06/19/2008 | US20080148425 Transgenic seeds for use in propagation of disease, herbicide and insect resistant plants with enhanced carbohydrate and fatty acid metabolism |
| 06/19/2008 | US20080148424 Plants and seeds of corn variety lh313 |
| 06/19/2008 | US20080148423 Transgenic seeds for use in propagation of disease, herbicide and insect resistant plants with enhanced carbohydrate and fatty acid metabolism |
| 06/19/2008 | US20080148421 Transgenic seeds for use in propagation of disease, herbicide and insect resistant plants with enhanced carbohydrate and fatty acid metabolism |
| 06/19/2008 | US20080148420 Transgenic seeds for use in propagation of disease, herbicide and insect resistant plants with enhanced carbohydrate and fatty acid metabolism |
| 06/19/2008 | US20080148416 Animal models for monitoring activity of drug metabolizing enzymes; side effect reduction; assessing xenobiotics |
| 06/19/2008 | US20080147199 Tissue scaffold having aligned fibrils, apparatus and method for producing the same, and artificial tissue and methods of use thereof |
| 06/19/2008 | US20080146660 Androgen receptor antagonists; certain cancers such as colon, skin and prostate cancer, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired |
| 06/19/2008 | US20080146555 Uses of Kinase Inhibitors and Compositions Thereof |
| 06/19/2008 | US20080146521 Adhesive N, O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins |
| 06/19/2008 | US20080146507 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor |
| 06/19/2008 | US20080146506 Methods of Suppressing Microglial Activation |
| 06/19/2008 | US20080146505 47 Human Secreted Proteins |
| 06/19/2008 | US20080146503 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins |
| 06/19/2008 | US20080146447 Applying to crop plants and weeds a pyruvic acid dioxygenase inhibitor to control weeds without affecting the growth |
| 06/19/2008 | US20080145943 Cng2b: a novel human cyclic nucleotide-gated ion channel |
| 06/19/2008 | US20080145937 In Vivo Transformation of Pancreatic Acinar Cells into Insulin-Producing Cells |
| 06/19/2008 | US20080145936 Control of ES Cell Self Renewal and Lineage Specification, and Medium Therefor |
| 06/19/2008 | US20080145935 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 06/19/2008 | US20080145934 Tissue-engineering scaffolds containing self-assembled-peptide hydrogels |
| 06/19/2008 | US20080145933 Systems and methods for parenterally procuring bodily-fluid samples with reduced contamination |
| 06/19/2008 | US20080145932 Method and apparatus for cell recovery |
| 06/19/2008 | US20080145931 signaling cells with an interferon gamma receptor agonists and tumor necrosis factor agonists, then with a second signal comprising a CD40 agonist and natural killer cells, to produce chemokine receptor (CCR7) mature cells, used as immunostimulants |
| 06/19/2008 | US20080145930 Using serial dilution of cryoprotectant as means of reactivating freeze preserved animal oocytes |
| 06/19/2008 | US20080145929 Method For the Preparation of a Dermal Papilla Tissue Having Hair Follicle Inductive Potency |
| 06/19/2008 | US20080145928 Nucleotide sequences coding transcription factor for use in prevention and treatment of cell proliferative disorders |
| 06/19/2008 | US20080145895 Expression vector comprising nucleotide sequences coding light and heavy chain immunoglobulin segments for use as efficient gene transfer element in genetic engineering and gene therapy |
| 06/19/2008 | US20080145893 Using chineese hamster ovaries as bioreactors for biosynthesis of immunoglobulin lihgt and heavy chains |
| 06/19/2008 | US20080145889 Using pancreatic inslet stem cell as drug testing models; tissue engineering and regenerative medicine |
| 06/19/2008 | US20080145884 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 06/19/2008 | US20080145872 Expression of HLA proteins on non human cells |
| 06/19/2008 | US20080145866 Modified human thymic stromal lymphopoietin |
| 06/19/2008 | US20080145861 Methods of protein production in cell lines |
| 06/19/2008 | US20080145860 Encapsulated cell indicator system |
| 06/19/2008 | US20080145859 Diagnosis and treatment of cancer |
| 06/19/2008 | US20080145855 Mutations in the Ferroportin 1 Gene Associated with Hereditary Haemochromatosis |
| 06/19/2008 | US20080145834 Determining clotting capability of fresh blood and/or blood components using lypholized blood products |
| 06/19/2008 | US20080145381 Multi-subtype FIV vaccines |
| 06/19/2008 | US20080145377 G-CSF Polypeptides And Uses Thereof |
| 06/19/2008 | US20080145376 Vectors And Methods For Genetic Immunization |
| 06/19/2008 | US20080145366 Platelet derived growth factor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders; antisense agents; antitumor agents |
| 06/19/2008 | US20080145365 Human and mammalian stem cell-derived neuron survival factors |
| 06/19/2008 | US20080145359 Imaging, diagnosis and treatment of disease |
| 06/19/2008 | US20080145348 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 06/19/2008 | US20080145347 p-Hyde sequences in the Rat |
| 06/19/2008 | US20080145345 Extracting bone marrow from patient;processing bone marrow and isolating mononuclear cells within closed system; administering mononuclear cells to patient; treating cardiovascular disorders; tissue repair |
| 06/19/2008 | US20080145344 Dermal wound dressing comprising non-contractile bioscaffold for use in treatment of injury |
| 06/19/2008 | US20080145343 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 06/19/2008 | US20080145340 Neuroactive agents and methods of their use |
| 06/19/2008 | CA2763879A1 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 06/19/2008 | CA2673085A1 Transferrin fusion protein libraries |
| 06/19/2008 | CA2671812A1 Highly efficient gas permeable devices and methods for culturing cells |
| 06/19/2008 | CA2658836A1 Uses of disease gene promoters for providing therapeutic cell populations |
| 06/18/2008 | EP1932917A2 Plant sterol acyltransferases |
| 06/18/2008 | EP1932914A2 Caspase-9 deficient animals and the use thereof |
| 06/18/2008 | EP1932911A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 06/18/2008 | EP1932909A1 Plant producing hyaluronic acid |
| 06/18/2008 | EP1932908A1 Reporter vector for use in evaluation of cyp1a2 induction |